
Detection of Helicobacter in Shelter dogs / Gökalp et al. ____________________________________________________________________________
2 of 7
INTRODUCTION
Helicobacter is a genus of gram–negative, microaerophilic, spiral 
bacteria containing more than 40 species. Non–Helicobacter pylori 
helicobacteria (NHPHs) such as Helicobacter heilmannii sensu stricto 
(s.s.), Helicobacter bizzozeronii and Helicobacter felis have been 
frequently detected in the stomach of dogs (Canis lupus familiaris) 
and cats (Felis catus) [1]. The main types of NHPH found in dogs are H. 
heilmannii s.s., H. bizzozeronii, H. salomonis, H. felis and H. canis [2]. 
Most of the NHPHS may also cause illness in humans. Attention should 
be paid to the zoonotic importance of NHPHS due to the increased 
risk of occurrence in people who are in close and intense contact with 
animals [3]. Since Helicobacter pathogens can be excreted through 
defecation, expectorating, and vomiting, they present faecal–oral, 
oral–oral and gastro–oral transmission routes [4]. Dogs are the natural 
hosts of NHPH and harbour these bacteria in their gastric mucosa, 
are possible sources of transmission of these bacteria to humans [2].
Invasive and non–invasive methods are used in the diagnosis of 
Helicobacter infection. Among invasive methods with endoscopic 
biopsy, histological examination, culture, rapid urease test (RUT), 
and polymerase chain reaction (PCR) are shown; while among non–
invasive methods, faecal antigen test, urea breath test (UBT), and 
serological tests are named [5]. Although gastroscopy, which is within 
than other methods, it should be noted that many veterinarians do not 
have the opportunity and ability to perform gastroscopy, in addition to 
the risks of gastroscopy and associated anaesthesia. For this reason, 
non–invasive methods such as serology, culture or PCR, which can 
be made from blood, saliva and faecal samples, are preferred [6]. In 
addition, it was reported in a study that PCR analyses alone would not 
state in the diagnosis of Helicobacter, and this should be supported 
by histopathological analyses [7].
The faecal antigen test is highly accurate and a rapid test that 
and after treatment. The simplicity of the present method does not 
require prior preparation of the patient, but it is recommended not 
to apply a proton pump inhibitor (PPI), a 4–week antibiotic treatment, 
and bismuth compounds two weeks before the test is performed [8].
Erythrocyte synthesis is regulated by many factors such as 
erythropoietin, B
12
, folic acid, and vitamin C. Helicobacter infections 
have been associated with vitamin B
12
causing the persistence of vitamin B
12
9]. In addition, it is 
known that high levels of TNF–alpha and interleukin levels are present 
in Helicobacter
cause structural changes in the gastric epithelial cells [10].
It has been reported that all Helicobacter species are highly sensitive to 
and neomycin, and over 90% of dogs with Helicobacter–induced gastritis 
are relieved by using a combination of metronidazole, amoxicillin and 
famotidine. This treatment procedure, known as triple therapy, lasts at least 
21 days, increasing the chance of eradication [11]. The aim of the study was 
to determine the presence of Helicobacter in dogs by fecal antigen test and 
ELISA methods and to provide early treatment, to have information about 
α, IL–1β and C–reactive 
protein concentrations and to measure the effects of the presence of the 
agent on folic acid (FA) and cobalamin (COB) concentrations.
MATERIALS AND METHODS
Study population and experimental design
The population consisted of 82 dogs in the Temporary Animal 
Shelter of the Municipality of Sorgun. Priority was given to those 
sampled dogs which showed signs of vomiting and gastritis. Sampling 
was done from 82 dogs in the form of scanning. The samples were 
collected from different groups of breed, gender and age. Sampling 
was done by screening from 82 dogs. Samples were collected from 
different breeds, sex and age groups. Samples were composed of 47 
dogs from the 0 > 2 age group, 35 dogs from the 2 > 4 age group, 45 
dogs from the female animal group and 37 dogs from the male animal 
group. According to faecal antigen test results, 2 (4,25%) dogs from 
0 > 2 age group and 4 (11,4%) dogs from 2 > 4 age group were positive 
for Helicobacter antigen. These dogs were formed the infected group 
(n=6) and the antigen negative dogs (n=6) were formed the control 
group. The study counted with the approval of the Erciyes University 
Animal Experiments Local Ethics Committee (10.09.2020, 20/128).
Clinical examination
The clinical examination of the 82 dogs was performed. The animals 
were examined for signs such as loss of appetite, vomiting, abdominal 
pain, and increased urge to drink water with dehydration.
Blood and faecal collection
Clinical symptoms frequently encountered in infections originating 
from Helicobacter were considered while sampling. 82 dogs with 
of sampling were included in the study. For faecal antigen testing, faecal 
samples were collected from the rectal region. Blood samples were 
taken via vena jugularis into EDTA tubes (Vacusel, Konya, Türkiye) for 
haematological analysis; into vacuum tubes (BD Vacutainer, Plymouth, 
United Kingdom) for biochemical and serological analysis. The blood 
samples obtained were centrifuged in a cooled centrifuge (Hettich 
Universal 320R, Germany) at 4.000 g·5 min
-1
. After centrifugation, the 
serum was stored at -80°C (ESCO, ESC–UUS–480A, Singapore) until 
biochemical and serological analysis.
Treatment protocol
It was paid attention that no antimicrobial treatment was 
administered to the dogs for the previous week and that the dogs 
sampled were at least one year old. In the dogs to be sampled, those 
showing symptoms of vomiting and gastritis were prioritized, and 
scanning was performed on 82 dogs that formed the material of the 
study. Faecal antigen tests were performed on the faecal samples. 
According to the results of faecal antigen tests, positivity (n=6) and 
negativity (n=6) were determined. Those found positive were accepted 
as infected group and treatment was applied. The infected group 
was treated according to the protocol known as triple therapy used 
in Helicobacter infections. Amoxicillin–Clavulanate (Croxilex–BID 625 
mg tablet, Turkey) 20 mg·kg
-1
 PO once a day, Metronidazole (Flagyl 
500 mg tablet, France) 15 mg·kg
-1
 PO once a day, Ranitidine (Ranitab 
150 mg tablet, Turkey) 4 mg·kg
-1
 PO once a day. After treatment, stool 
samples were collected with sterile test apparatus for 3 weeks and 
stool antigen test was repeated.